Laman UtamaAGIO • NASDAQ
add
Agios Pharmaceuticals Inc
$38.80
Selepas Waktu Dagangan:(0.00%)0.00
$38.80
Tutup: 22 Ogo, 8:00:00 PTG GMT-4 · USD · NASDAQ · Penafian
Tutup sebelumnya
$38.20
Julat hari
$37.75 - $39.69
Julat tahun
$23.42 - $62.58
Permodalan pasaran
2.25B USD
Bilangan Purata
880.78K
Nisbah P/E
3.51
Hasil dividen
-
Pertukaran utama
NASDAQ
Dalam berita
Kewangan
Penyata Pendapatan
Hasil
Pendapatan bersih
| (USD) | Jun 2025info | Perubahan T/T |
|---|---|---|
Hasil | 12.46J | 44.57% |
Perbelanjaan pengendalian | 45.87J | 29.08% |
Pendapatan bersih | -112.02J | -16.54% |
Margin untung bersih | -899.40 | 19.39% |
Pendapatan bagi setiap syer | -1.93 | -14.20% |
EBITDA | -125.80J | -20.70% |
Kadar cukai berkesan | — | — |
Kunci Kira-kira
Jumlah aset
Jumlah liabiliti
| (USD) | Jun 2025info | Perubahan T/T |
|---|---|---|
Pelaburan tunai dan jangka pendek | 938.94J | 64.76% |
Jumlah aset | 1.47B | 90.31% |
Jumlah liabiliti | 101.68J | -9.66% |
Jumlah ekuiti | 1.37B | — |
Syer tertunggak | 58.10J | — |
Harga kepada buku | 1.62 | — |
Pulangan pada aset | -20.99% | — |
Pulangan pada modal | -21.62% | — |
Aliran Tunai
Perubahan bersih dalam tunai
| (USD) | Jun 2025info | Perubahan T/T |
|---|---|---|
Pendapatan bersih | -112.02J | -16.54% |
Tunai daripada operasi | -77.12J | -6.25% |
Tunai daripada pelaburan | 78.97J | 112.02% |
Tunai daripada pembiayaan | 65.00K | -94.09% |
Perubahan bersih dalam tunai | 1.91J | 105.57% |
Aliran tunai bebas | -51.97J | -32.43% |
Perihal
Agios Pharmaceuticals Inc. is a publicly trading American pharmaceutical company pioneering therapies for genetically defined diseases, with a near-term focus on developing therapies for hemolytic anemias. The company was founded in 2008 by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. The company tendered an initial public offering in July 2013. Wikipedia
Diasaskan
2008
Tapak web
Pekerja
487
